pim1in1

PIM1-IN-1 is a potent and highly selective inhibitor of PIM1/3(IC50s of 7, 5530 and 70 nM for PIM1, PIM2, and PIM3, respectively),with Antiproliferative and anti-cancer activity.

CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1 (IC50s: 3.787 μM and 4.327 μM). It is developed for the research of proliferative disorders such as cancer, as well as other kinase-associated conditions.

CDK2/PIM1-IN-1 是一种 CDK2 (IC50: 0.27 μM) 和 PIM1 (IC50: 0.67 μM) 激酶的抑制剂。它能够诱导细胞凋亡 (apoptosis)，并抑制 TNF-α 的表达，从而展现出抗肿瘤活性。

CDK6/PIM1-IN-1 (Compound 51) hydrochloride 是一种有效的口服双重CDK6/PIM1抑制剂，IC50值分别为39 nM和88 nM。此化合物也抑制CDK4 (IC50=3.6 nM)，并明显抑制急性髓系白血病(AML)细胞的增殖，将细胞周期阻止在G1期，同时促进细胞凋亡(apoptosis)，展现出抗AML活性。

CDK6/PIM1-IN-1 是一种平衡的、有效的、双重 CDK6 (IC50: 39 nM) 和 PIM1 (IC50: 88 nM) 抑制剂。CDK6/PIM1-IN-1 对 CDK4 表现出抑制作用，其 IC50 值为 3.6 nM。CDK6/PIM1-IN-1 能够明显抑制急性髓系白血病 (AML) 细胞增殖，将细胞周期阻滞在 G1 期并诱导细胞凋亡。CDK6/PIM1-IN-1 表现出抗 AML 活性。